1. Hauptnavigation
  2. Navigation des Hauptbereiches
  3. Inhalt der Seite

Press Officer and Head of Press and Public Relations

Dr. Stefanie Seltmann
Dr. Stefanie Seltmann

Im Neuenheimer Feld 280
69120 Heidelberg

Phone: +49 6221 422854
Fax: +49 6221 422968

E-Mail: s.seltmann@dkfz.de
or presse@dkfz.de

Recent Press Releases

No. 05c | 03. February 2016

Aurelio Teleman honored with 2015/2016 Johann Georg Zimmermann-Prize

Aurelio Teleman honored with 2015/2016 Johann Georg Zimmermann-Prize

For over 40 years now, the Deutsche Hypothekenbank AG (Deutsche Hypo) has awarded the Johann Georg Zimmermann Prize to honor outstanding scientific achievements in the field of cancer research. This year’s award goes to Aurelio Teleman from the German Cancer Research Center (DKFZ). Aurelio, a biochemist, is studying molecular signaling pathways that regulate metabolism in cells. Defects in these signaling pathways can lead to cancer.

No. 05 | 02. February 2016 | by AM

DKTK: Incentive for clinically relevant cancer research: Joint Funding Contest rewards outstanding methods of diagnosis and therapy

DKTK: Incentive for clinically relevant cancer research: Joint Funding Contest rewards outstanding methods of diagnosis and therapy

The enormous growth in knowledge in cancer research presents physicians and scientists with the challenge of ensuring that patients not only benefit from the latest insights and developments but also as quickly as possible. The Joint Funding Contest organized by the German Cancer Consortium (DKTK) has created new momentum for knowledge transfer into clinical application. This year, the consortium honoured 4 studies investigating approaches for personalized cancer therapies, a diagnostic method for early detection of prostate cancer, and immunotherapy for clinical application in children. The DKTK combines the DKFZ in Heidelberg as the core center with other German centres specialized in the research and treatment of oncological diseases.

No. 03c3 | 01. February 2016 | by Koh

Inspired by nature: Promising new synthetic anticancer agent

Inspired by nature: Promising new synthetic anticancer agent

Scientists from the German Cancer Research Center (DKFZ) have succeeded in synthesizing a compound that mimics the three-dimensional structure of a promising anticancer agent called fumagillin. The synthetic substance proved effective in cell culture and was significantly more stable than the natural compound. It will serve as a starting compound that will be further optimized with the goal of developing a drug against cancer and also against obesity.

Audio (in German only)
einblick (in German only)
Publications
Videos (in German only)
last update: 16/10/2013 back to top